14 completed, 1 terminated. 15 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 14, Terminated 1 |
Follow Cocaine Abuse: new trials by email Literature Review of Cocaine Abuse trials Research Report on Cocaine Abuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study Clavulanic acid, Intravenous cocaine, Placebo - Cocaine Dependence, Cocaine Addiction | Phase 1 | Completed | Temple University | 10 | 2016-10-24 | 2023-11-03 |
| Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin Lorcaserin, Placebo, Cocaine Infusion - Cocaine Abuse | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 20 | 2015-05-01 | 2017-01-11 |
| Pramipexole as a Treatment for Cocaine Dependence Pramipexole, Placebo - Cocaine Addiction, Cocaine Abuse | Phase 1 | Completed | Baylor College of Medicine | 10 | 2011-10-01 | 2014-07-22 |
| ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine ALKS 33-BUP, ALKS 33, Placebo - Cocaine Abuse | Phase 1 | Completed | Alkermes, Inc. | 33 | 2011-08-01 | 2012-03-09 |
| A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence Placebo, Cabergoline - Cocaine Dependence, Cocaine Abuse | Phase 1 | Completed | Baylor College of Medicine | 11 | 2011-07-01 | 2012-07-27 |
| Modafinil - Escitalopram Study for Cocaine Dependence Modafinil and Escitalopram, Placebo, Modafinil - Cocaine Dependence, Cocaine Abuse | Phase 1 | Completed | Baylor College of Medicine | 68 | 2010-08-01 | 2012-05-18 |
| Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) L-dopa / carbidopa / entacapone (LCE) - Cocaine Abuse | Phase 1 | Completed | New York State Psychiatric Institute | 15 | 2010-08-01 | 2018-05-21 |
| The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine Placebo, Doxazosin - Cocaine Addiction, Cocaine Abuse | Phase 1 | Completed | Baylor College of Medicine | 13 | 2010-01-01 | 2012-07-27 |
| Rivastigmine and Huperzine A as Treatments for Cocaine Dependence Placebo, Rivastigmine 3 mg, Huperzine A 0.4 mg - Cocaine Dependence, Cocaine Addiction | Phase 1 | Completed | Baylor College of Medicine | 72 | 2009-01-01 | 2015-01-27 |
| Computer-Based Training in Cognitive Behavior Therapy Treatment as usual (TAU), CBT for CBT - Cocaine Abuse | Phase 1 | Completed | Yale University | 100 | 2007-11-01 | 2013-01-29 |
| Effect of Clonidine on Responses to Imagery Scripts Clonidine, Placebo - Cocaine Abuse, Heroin Abuse | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 92 | 2005-06-14 | 2018-04-05 |
| CBT With Disulfiram and Contingency Management disulfiram, Placebo, Placebo plus Contingency Management - Cocaine Abuse | Phase 1 | Completed | Yale University | 181 | 2005-04-01 | 2014-12-03 |
| Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals GBR 12909 - Cocaine Abuse, Cocaine-Related Disorders | Phase 1 | Terminated | National Institute on Drug Abuse (NIDA) | 3 | 2004-12-01 | 2017-01-12 |
| Long Term Maintenance of Drug Abstinence Contingency Management - Cocaine Dependence, Cocaine Abuse | Phase 1 | Completed | Treatment Research Institute | 166 | 2004-09-01 | 2023-03-28 |
| Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse Methadone, Contingency Management - Opioid Dependence, Cocaine Abuse | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 200 | 1999-06-01 | 2017-01-12 |
Cocaine-Related Disorders (15) · Substance-Related Disorders (6) · Heroin Dependence (1) · Opioid-Related Disorders (1) · Recurrence (1)
Chemically-Induced Disorders (15) · Mental Disorders (15) · Substance-Related Disorders (9) · Narcotic-Related Disorders (2) · Disease Attributes (1) · Opioid-Related Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Sugars (5) · Buprenorphine (1) · Cabergoline (1) · Carbidopa (1) · Clavulanic Acid (1) · Clonidine (1) · Disulfiram (1) · Doxazosin (1) · Escitalopram (1) · Levodopa (1) · Methadone (1) · Modafinil (1) · Pramipexole (1) · Rivastigmine (1) · Therapeutics (1)
Baylor College of Medicine (5) · National Institute on Drug Abuse (NIDA) (4) · Yale University (2) · Alkermes, Inc. (1) · New York State Psychiatric Institute (1) · Temple University (1) · Treatment Research Institute (1)
United States (14)
Adam Bisaga, M.D. (1) · Bernard L. Silverman, MD (1) · Debra Kelsh, Ph.D. (1) · John Grabowski, PhD (1) · Kathleen Carroll, PhD (1) · Kathleen M. Carroll, PhD (1) · Kenzie Preston, Ph.D. (1) · Kenzie Preston, PhD (1) · Kimberly C Kirby, Ph.D. (1) · Kyle M. Kampman, M.D. (1) · M. I Walters, M.D. (1) · Mary F. Morrison, M.D., M.S. (1) · Richard De La Garza, II, PhD (1) · Richard De La Garza, Ph.D. (1) · Thomas Newton, MD (1)
PMID 22775772, PMID 42423707, PMID 16887281, PMID 17084789, PMID 17523584, PMID 17624688, PMID 17907858, PMID 17931826, PMID 18068905, PMID 21190403, PMID 22319592, PMID 22695473, PMID 24577287, PMID 25982006, PMID 26239766, PMID 27658192, PMID 30240978
P50DA018197 (2), 1RC1DA028387 (1), P50DA009236 (1), R01DA017444 (1), R01DA019078 (1), R01DA023624 (1), R01DA031000 (1), U54DA039002 (1)